The British Broadcasting Corporation (BBC) reported that the first vaccine against dengue will go on sale in early 2016 and that the vaccine could reduce the mortality rate from the disease by 50 percent in just four years.
Olivier Charmeil, CEO of Sanofi Pasteur, the company producing the vaccine, said “We want to reduce dengue mortality by 50 percent and morbidity by 25 percent by 2020.”
Charmeil told the BBC that according to previous studies in 20,800 volunteers in Latin America, the vaccine would have a preventive rate of 95.5 percent. He said that such effectiveness would help avoid the most severe cases of dengue and reduce the hospitalization rate by 80 percent.
The CEO said, “Until now the only way to combat dengue was to eliminate the insect that transmits it, but as of January 2016 will be another weapon: a vaccine.”
According to data from the World Health Organization, 390 million people are infected with dengue each year, 100 million of them seriously.
(from Diario de Yucatán)